Your browser doesn't support javascript.
loading
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Benson, Al B; D'Angelica, Michael I; Abrams, Thomas; Abbott, Daniel E; Ahmed, Aijaz; Anaya, Daniel A; Anders, Robert; Are, Chandrakanth; Bachini, Melinda; Binder, David; Borad, Mitesh; Bowlus, Christopher; Brown, Daniel; Burgoyne, Adam; Castellanos, Jason; Chahal, Prabhleen; Cloyd, Jordan; Covey, Anne M; Glazer, Evan S; Hawkins, William G; Iyer, Renuka; Jacob, Rojymon; Jennings, Lawrence; Kelley, R Kate; Kim, Robin; Levine, Matthew; Palta, Manisha; Park, James O; Raman, Steven; Reddy, Sanjay; Ronnekleiv-Kelly, Sean; Sahai, Vaibhav; Singh, Gagandeep; Stein, Stacey; Turk, Anita; Vauthey, Jean-Nicolas; Venook, Alan P; Yopp, Adam; McMillian, Nicole; Schonfeld, Ryan; Hochstetler, Cindy.
Afiliação
  • Benson AB; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • D'Angelica MI; Memorial Sloan Kettering Cancer Center.
  • Abrams T; Dana-Farber/Brigham and Women's Cancer Center.
  • Abbott DE; University of Wisconsin Carbone Cancer Center.
  • Ahmed A; Stanford Cancer Institute.
  • Anaya DA; Moffitt Cancer Center.
  • Anders R; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Are C; Fred & Pamela Buffett Cancer Center.
  • Bachini M; The Cholangiocarcinoma Foundation.
  • Binder D; University of Colorado Cancer Center.
  • Borad M; Mayo Clinic Comprehensive Cancer Center.
  • Bowlus C; UC Davis Comprehensive Cancer Center.
  • Brown D; Vanderbilt-Ingram Cancer Center.
  • Burgoyne A; UC San Diego Moores Cancer Center.
  • Castellanos J; Fox Chase Cancer Center.
  • Chahal P; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Cloyd J; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Covey AM; Memorial Sloan Kettering Cancer Center.
  • Glazer ES; The University of Tennessee Health Science Center.
  • Hawkins WG; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Iyer R; Roswell Park Comprehensive Cancer Center.
  • Jacob R; O'Neal Comprehensive Cancer Center at UAB.
  • Jennings L; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Kelley RK; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Kim R; Huntsman Cancer Institute at the University of Utah.
  • Levine M; Abramson Cancer Center at the University of Pennsylvania.
  • Palta M; Duke Cancer Institute.
  • Park JO; Fred Hutchinson Cancer Center.
  • Raman S; UCLA Jonsson Comprehensive Cancer Center.
  • Reddy S; Fox Chase Cancer Center.
  • Ronnekleiv-Kelly S; University of Wisconsin Carbone Cancer Center.
  • Sahai V; University of Michigan Rogel Cancer Center.
  • Singh G; City of Hope National Medical Center.
  • Stein S; Yale Cancer Center/Smilow Cancer Hospital.
  • Turk A; Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
  • Vauthey JN; The University of Texas MD Anderson Cancer Center.
  • Venook AP; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Yopp A; UT Southwestern Simmons Comprehensive Cancer Center.
  • McMillian N; National Comprehensive Cancer Network.
  • Schonfeld R; National Comprehensive Cancer Network.
  • Hochstetler C; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 21(7): 694-704, 2023 07.
Article em En | MEDLINE | ID: mdl-37433432
ABSTRACT
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Neoplasias do Sistema Biliar / Colangiocarcinoma / Neoplasias da Vesícula Biliar / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: J Natl Compr Canc Netw Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Neoplasias do Sistema Biliar / Colangiocarcinoma / Neoplasias da Vesícula Biliar / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: J Natl Compr Canc Netw Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article